Pure Global

Abbott second-generation total bilirubin assay set - Taiwan Registration 8593a6d9031f55d294c359e6bf24983b

Access comprehensive regulatory information for Abbott second-generation total bilirubin assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8593a6d9031f55d294c359e6bf24983b and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
8593a6d9031f55d294c359e6bf24983b
Registration Details
Taiwan FDA Registration: 8593a6d9031f55d294c359e6bf24983b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott second-generation total bilirubin assay set
TW: ไบžๅŸน็ฌฌไบŒไปฃ็ธฝ่†ฝ็ด…็ด ๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 2

Registration Details

8593a6d9031f55d294c359e6bf24983b

DHA05603585300

Company Information

Product Details

This product is used to quantify total bilirubin in human serum or plasma in adults and newborns on the Alinity c System.

A Clinical chemistry and clinical toxicology

A.1110 Bilirubin (total or direct) test system

Input;; QMS/QSD

Dates and Status

Sep 21, 2022

Sep 21, 2027